My Top Under-the-Radar Artificial Intelligence (AI) Growth Stock to Buy Now
At a six-month low, Adobe is looking like a worthy turnaround play.
Stay updated with breaking news from Development Expense. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
At a six-month low, Adobe is looking like a worthy turnaround play.
Fully enrolled two Phase 2 studies with data from both expected in the second half of 2024First patient dosed in new Phase 2 breast cancer prevention studyData from ongoing Phase
Management to host a conference call today at 8:30 am ET...
FLORHAM PARK, N.J., March 27, 2024 -- Cellectar Biosciences, Inc. , a late-stage clinical biopharmaceutical company focused on the discovery, development, and commercialization of drugs for the...
Puma Biotechnology, Inc. , a biopharmaceutical company, announced financial results for the fourth quarter and year ended December 31, 2023. Unless otherwise stated, all comparisons are for the...